EA201991791A3 - Гетероциклиламины как ингибиторы pi3k - Google Patents

Гетероциклиламины как ингибиторы pi3k

Info

Publication number
EA201991791A3
EA201991791A3 EA201991791A EA201991791A EA201991791A3 EA 201991791 A3 EA201991791 A3 EA 201991791A3 EA 201991791 A EA201991791 A EA 201991791A EA 201991791 A EA201991791 A EA 201991791A EA 201991791 A3 EA201991791 A3 EA 201991791A3
Authority
EA
Eurasian Patent Office
Prior art keywords
heterocyclylamines
pi3k inhibitors
pi3k
activity
diseases
Prior art date
Application number
EA201991791A
Other languages
English (en)
Other versions
EA201991791A2 (ru
Inventor
Юнь-Лун Ли
Вэньцин Яо
Эндрю П. Комбс
Эдди В. Юэ
Сун Мей
Вэньюй Чжу
Джозеф Гленн
Томас П. мл. Мадускуи
Ричард Б. Спаркс
Брент Даути
Чуньхун Хэ
Original Assignee
Инсайт Холдингс Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инсайт Холдингс Корпорейшн filed Critical Инсайт Холдингс Корпорейшн
Publication of EA201991791A2 publication Critical patent/EA201991791A2/ru
Publication of EA201991791A3 publication Critical patent/EA201991791A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

В настоящем изобретении представлены производные гетероциклиламина формулы Iгде переменные являются такими, как описано в описании изобретения, которые модулируют активность фосфоинозитид 3-киназ (PI3K) и подходят для лечения заболеваний, связанных с активностью PI3K, включая, например, воспалительные расстройства, иммунные расстройства, рак и другие заболевания.
EA201991791A 2012-07-30 2012-08-31 Гетероциклиламины как ингибиторы pi3k EA201991791A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261677445P 2012-07-30 2012-07-30

Publications (2)

Publication Number Publication Date
EA201991791A2 EA201991791A2 (ru) 2019-12-30
EA201991791A3 true EA201991791A3 (ru) 2020-03-31

Family

ID=69061905

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991791A EA201991791A3 (ru) 2012-07-30 2012-08-31 Гетероциклиламины как ингибиторы pi3k

Country Status (1)

Country Link
EA (1) EA201991791A3 (ru)

Also Published As

Publication number Publication date
EA201991791A2 (ru) 2019-12-30

Similar Documents

Publication Publication Date Title
EA201791929A1 (ru) Гетероциклиламины как ингибиторы pi3k
MX2023000410A (es) Analogos de rapamicina como inhibidores de mtor.
CY1120866T1 (el) Παρεμποδιστες dna-pk
EA201270100A1 (ru) Пиримидиноны в качестве ингибиторов pi3k
EA201490042A1 (ru) Азетидинил-фенил-, пиридил- или пиразинилкарбоксамидные производные как ингибиторы jak
PH12016501160A1 (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
MX352928B (es) Compuestos de piridazina-amida.
EA201690007A1 (ru) Соединения, ингибирующие металлоферменты
MX2022010638A (es) Inhibidores de pde9 para el tratamiento de enfermedades perifericas.
PH12016502291A1 (en) Indolizine derivatives as phosphoinositide 3-kinases inhibitors
EA201591360A1 (ru) Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
EA201400339A1 (ru) Новые имидазоламины в качестве модуляторов киназной активности
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
SG10201900954SA (en) Heterocycles as Modulators of Kinase Activity
UY34843A (es) Tratamiento de enfermedades inflamatorias oculares usando laquinimod
EA201600002A1 (ru) Производные пролекарства замещенных триазолопиридинов
EA201500737A1 (ru) Пиразолилкарбоксамиды ii в качестве ингибиторов crac каналов
EA201991791A3 (ru) Гетероциклиламины как ингибиторы pi3k
UA112552C2 (uk) Гетероцикліламіни як інгібітори pi3k
MX2015016760A (es) Derivados de ftalazina.
UA110978C2 (uk) Азетидинілфенілові, піридилові або піразинілкарбоксамідні похідні як інгібітори jak
UA108989C2 (en) PIRIMIDINONS AS PI3K INHIBITORS